Sort
53,477 grants matching “addiction”
PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT. JULY 9, 2022 - JULY 8, 2027
$466,040Scott P Runyon · Research Triangle Institute · N01 · FY2023 · DA
Impact of Flavor on Youth & Young Adults use Intention, Abuse Liability and Perceptions of Cigarillos
$465,980Erika S Trapl · Case Western Reserve University · R01 · FY2020 · DA
FRONT-LOADED COUNSELING TO TREAT TOBACCO ADDICTION
$465,968Harvard University (Medical School) · R01 · FY2004 · DA
Advancing Perceived Message Effectiveness: A New Measure for Youth Prevention Media Campaigns
$465,932Seth Michael Noar · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Modulators of Metabotropic Glutamate Receptor Subtype 2 for Cocaine Dependence
$465,911Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · DA
Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts among Regular Electronic Cigarette Users
$465,883Melissa D Blank · West Virginia University · R15 · FY2025 · DA
A critical role for rapid estrogen signaling in alcohol addiction and anxiety
$465,860Kristen Elizabeth Pleil · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AA
Development of Orexin-1 Receptor Antagonists to Prevent Drug Relapse
$465,843Paul J Kenny · Scripps Florida · R01 · FY2011 · DA
The Genetics Of Obsessive Compulsive Disorder
$465,840Dennis L Murphy · National Institute Of Mental Health · Z01 · FY2008 · MH
A critical role for rapid estrogen signaling in alcohol addiction and anxiety
$465,824Kristen Elizabeth Pleil · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AA
Epitranscriptomic Regulation of Synaptic Responses to Drugs of Abuse
$465,766Kathryn D Meyer · Duke University · DP1 · FY2019 · DA
Novel Mu Opioid Receptor Modulators to Counteract Synthetic Opioids
$465,750Piyusha P Pagare · Virginia Commonwealth University · DP1 · FY2025 · DA
Adrenergic Pharmacotherapies for d-MA Depependence
$465,741California Pacific Med Ctr Res Institute · P50 · FY2005 · DA
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
$465,721Rockefeller University · P60 · FY2003 · DA
Communicating about Nicotine and Differential Risks of Tobacco Products
$465,673Lyudmila Popova · Georgia State University · R01 · FY2019 · CA
A mechanistic study of the role of the orexin system and insomnia within a buprenorphine opioid use disorder treatment sample
$465,669Caitlin Eileen Martin · Virginia Commonwealth University · R01 · FY2025 · DA
Medications Development for Drug Abuse Disorders
$465,669Johns Hopkins University · R01 · FY2005 · DA
Structural Basis of Opioid Receptor Function
$465,649Brian K Kobilka · Stanford University · R37 · FY2019 · DA
AN EVALUATION OF THE OXFORD HOUSE MODEL
$465,639De Paul University · R01 · FY2004 · AA
Kir 3 Channel Subunits in Drug Abuse with GABAB Agonists
$465,590Paul A Slesinger · Salk Institute For Biological Studies · R01 · FY2006 · DA
Predicting Effects of ENDS Flavor Regulations on Tobacco Behavior, Toxicity, and Abuse Liability among African American Menthol Smokers
$465,589Andrew James Barnes · Virginia Commonwealth University · R01 · FY2021 · DA
Frontostriatal Rhythms Underlying Reinforcement Learning.
$465,561Jonathan D Wallis · University Of California Berkeley · R01 · FY2021 · MH
Targeted Inhibition in Leukemia
$465,554Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Enabling ethical participation in innovative neuroscience on mental illness and addiction: towards a new screening tool enhancing informed consent for transformative research on the human brain
$465,508Laura W Roberts · Stanford University · R01 · FY2018 · MH
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
$465,468Carol Dawson-Rose · University Of California, San Francisco · RC1 · FY2009 · DA